In conclusion, our study showed no association between EGFR gene expression and presence of bone metastases in patients with NSCLC; however, patients with bone metastases had a higher RANKL gene expression and RANKL: OPG ratio. Here, EGFR is linked to non-small cell lung carcinoma.